Project Details
Project Description
Analysis of MRDR related to Incidence and clinical outcomes of functional high-risk multiple myeloma patients in Australia
Short title | MRDR Amgen High Risk Myeloma |
---|---|
Status | Finished |
Effective start/end date | 25/10/21 → 30/06/22 |
Funding
- Amgen (Australia): A$95,800.00
Keywords
- Myeloma High Risk Outcomes